Evidence map›Paper›PMID 28652394›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Lack of Both Nucleotide-Binding Oligomerization Domain-Containing Proteins 1 and 2 Primes T Cells for Activation-Induced Cell Death.

Sashi G Kasimsetty, Alana A Shigeoka, Andrew A Scheinok, Amanda L Gavin, Richard J Ulevitch, Dianne B McKay

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Resolving the field: a role for Nod2 in T cells.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  3. Review
  4. NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy.Computational intelligence and neuroscience · 2022
    Review
  5. Article
  6. Article
  7. B Cells Inhibit CD4Infection and immunity · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sashi G KasimsettyDivision of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla, CA 92093; and.ORCID 0000-0002-4748-9582
Alana A ShigeokaDivision of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla, CA 92093; and.ORCID 0000-0001-7227-5757
Andrew A ScheinokDivision of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla, CA 92093; and.
Amanda L GavinDepartment of Immunology and Microbial Sciences, Scripps Research Institute, La Jolla, CA 92037.ORCID 0000-0001-9921-4225
Richard J UlevitchDepartment of Immunology and Microbial Sciences, Scripps Research Institute, La Jolla, CA 92037.ORCID 0000-0001-8293-3127
Dianne B McKayDivision of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla, CA 92093; and d1mckay@ucsd.edu.ORCID 0000-0002-4857-6039
University of California San Diego · USScripps Research Institute · US

Funding

The Role of Inflammation in Ischemic Organ InjuryR01DK075718 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCKAY, DIANNE B · 2008 to 2012
$2.1M
Role of Nlrp3 in Ischemic Organ InjuryR01DK091136 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCKAY, DIANNE B · 2011 to 2015
$1.8M
Role of NOD2 in ischemia reperfusion injuryR01DK113162 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCKAY, DIANNE B · 2017 to 2020
$1.6M
NIDDK NIH HHS R01 DK075718NIDDK NIH HHS R01 DK091136NIDDK NIH HHS R01 DK113162
6 · The paper itself

Abstract

Nucleotide-binding oligomerization domain (Nod)-containing proteins Nod1 and Nod2 play important roles in the innate immune response to pathogenic microbes, but mounting data suggest these pattern recognition receptors might also play key roles in adaptive immune responses. Targeting Nod1 and Nod2 signaling pathways in T cells is likely to provide a new strategy to modify inflammation in a variety of disease states, particularly those that depend on Ag-induced T cell activation. To better understand how Nod1 and Nod2 proteins contribute to adaptive immunity, this study investigated their role in alloantigen-induced T cell activation and asked whether their absence might impact in vivo alloresponses using a severe acute graft versus host disease model. The study provided several important observations. We found that the simultaneous absence of Nod1 and Nod2 primed T cells for activation-induced cell death. T cells from

Indexed as

Lymphocyte ActivationAdaptive ImmunityAnimalsCell DeathDisease Models, AnimalDown-RegulationGenes, p53Graft vs Host DiseaseImmunity, InnateIsoantigensMiceNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinProto-Oncogene Proteins c-mdm2Receptors, Pattern RecognitionSignal TransductionIsoantigensMdm2 protein, mouseNod1 protein, mouseNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinProto-Oncogene Proteins c-mdm2Receptors, Pattern Recognition

Identifiers

PMID28652394
PMCPMC5600491
OpenAlexW2650633454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.